Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08:30am, Wednesday, 28'th Aug 2024
LOS ANGELES , Aug. 28, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "the C
MRNA LAWSUIT ALERT: Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
07:25am, Wednesday, 28'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK CITY, NY / ACCESSWIRE / August 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna,
October 8, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRNA
07:30pm, Tuesday, 27'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Moderna Enters Oversold Territory
12:56pm, Tuesday, 27'th Aug 2024
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec
The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MRNA
12:51pm, Tuesday, 27'th Aug 2024
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Moderna, Inc. (NASDAQ: MRNA).
Moderna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
12:30pm, Tuesday, 27'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
SAN DIEGO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of Moderna, Inc. (NASDAQ: MRNA) (“Moderna” or the “Company”) securities
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Moderna, Inc. (MRNA) Shareholders
11:30am, Tuesday, 27'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Investors in Moderna, Inc. Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
11:00am, Tuesday, 27'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Moderna Is Being Sued For Possibly Violating Securities Regulations And Shareholders Are Invited To Participate
11:00am, Tuesday, 27'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "th
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
10:48am, Tuesday, 27'th Aug 2024
A brand new round of Covid shots from Pfizer and Moderna is about to reach Americans. Meanwhile, CNBC tested out Dexcom's new CGM Stelo.
Can These 3 Nasdaq 100 Laggards Rebound in September?
09:26am, Tuesday, 27'th Aug 2024
Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher.
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna, Inc.
